Read More Details
Finally We wish PressBee provided you with enough information of ( FDA pulls authorization for COVID antibody treatment over lack of effectiveness )
Also on site :
FDA pulls authorization for COVID antibody treatment over lack of effectiveness ...Middle East
Evusheld, the preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the U.S. as it is most likely not effective against the strains of the coronavirus currently circulating. The announcement from the Food and Drug Administration (FDA) comes weeks after the agency issued a notice saying it did not expect Evusheld to be effective against the XBB.1.5 omicron subvariant, responsible for 61 percent of cases in the country, according to the most recent federal data. "Today’s action to limit the use of Evusheld prevents exposing patients to possible side effects of Evusheld such as allergic reactions, which can be potentially serious, at a time
Most Viewed News
جديد الاخبار